0.01Open0.01Pre Close298 Volume17.39K Open Interest30.00Strike Price298.00Turnover905.97%IV3.84%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0405Delta0.1416Gamma2890.00Leverage Ratio-12.5701Theta0.0000Rho117.11Eff Leverage0.0001Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.